News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Takara Bio To Provide RetroNectin To Childrens Hospital Los Angeles


10/19/2005 5:12:16 PM

Tokyo (JCNN) - Takara Bio (TSE: 4974) has announced that it will provide RetroNectin, its proprietary recombinant human fibronectin fragment, to Chidlrens Hospital Los Angeles (CHLA).

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES